HELEN CHEMERE: Open Payments
NPI 1972928620 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,281 in 127 payments from 26 companies in 2025. Trend: 2023 $1,238 · 2024 $2,901 · 2025 $3,281
Food & beverage: $3,281
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $453 |
| Lilly USA, LLC | 19 | $412 |
| CeQur Corporation | 1 | $331 |
| Corcept Therapeutics | 9 | $249 |
| Amgen Inc. | 11 | $203 |
| Abbott Laboratories | 8 | $177 |
| SANOFI-AVENTIS U.S. LLC | 9 | $162 |
| BETA BIONICS, INC. | 3 | $157 |
| ABBVIE INC. | 7 | $156 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $135 |
Products named: MOUNJARO, Ozempic, CeQur Simplicity, Korlym, JARDIANCE, TZIELD, iLet Bionic Pancreas, FREESTYLE LIBRE 3.
Industry payments across MD — which companies pay providers there.
